𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Changes in p14ARF do not play a primary role in human chondrosarcoma tissues

✍ Scribed by Julia Asp; Camilla Brantsing; Maria Serena Benassi; Sven Inerot; Luca Sangiorgi; Piero Picci; Anders Lindahl


Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
106 KB
Volume
93
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


The locus encoding the tumor suppressor p16 has been found to code for a second, different protein. This protein, p14(ARF), has been shown to protect p53 from degradation. Like p16, its gene is often altered in different cancers. In this study, the first unique exon, exon 1 beta, of p14(ARF), has been studied in 22 chondrosarcoma tissues using polymerase chain reaction, DNA sequencing and methylation-specific polymerase chain reaction. One chondrosarcoma was found to have exon 1 beta homozygously deleted, but neither mutations nor methylations were found in any of the chondrosarcomas. This indicates that genetic changes of p14(ARF) are a rare event in chondrosarcoma.


πŸ“œ SIMILAR VOLUMES


Changes of the p16 gene but not the p53
✍ Julia Asp; Luca Sangiorgi; Sven E. Inerot; Anders Lindahl; Lara Molendini; Maria πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 70 KB πŸ‘ 1 views

The role of two important tumour suppressor genes, p16 and p53, was evaluated in cartilaginous tumour tissues. Genomic DNA from 22 chondrosarcomas, 5 benign chondroid tumours, 1 sample of reactive proliferative cartilage and 2 samples of normal cartilage were analysed using polymerase chain reaction

Dystrophin and utrophin do not play cruc
✍ Jill A. Rafael; Jeffrey I. Trickett; Allyson C. Potter; Kay E. Davies πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 189 KB

The loss of full-length dystrophin from skeletal muscle leads to the clinical features of Duchenne muscular dystrophy. Both Dp71, a Cterminal dystrophin isoform, and the dystrophin-related protein, utrophin, are present at high levels in many nonmuscle tissues. To investigate the roles of these prot

Genetic alterations involving exon 3 of
✍ Bas P.L. Wijnhoven; Friedel Nollet; Nico J. De Both; Hugo W. Tilanus; Winand N.M πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 268 KB πŸ‘ 1 views

␀-catenin has been identified as an oncogene. Phosphorylation of sites encoded by exon 3 of the ␀-catenin gene facilitates degradation of this protein by the adenomatous polyposis coli (apc) gene product. Mutations in these sites or inactivation of apc lead to stabilization of ␀-catenin, which then